Founded in 2014, RainMed Medical is committed to becoming the world's leading panvascular interventional robotics company. Currently, it focusing on the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems. With independent innovation and great efforts, RainMed Medical has gradually built up a global R&D, production, sales and service network. RainMed Medical has actively cooperated with top medical centers and experts at home and abroad to build a perfect patent system. Many research results are continuously published in authoritative journals such as “Cardiovascular Research” and “JACC: Cardiovascular Interventions”. In addition, the company has signed strategic cooperation agreements with many top medical device distribution service platforms in China, developed a strict quality inspection system and perfect supply process, and successfully passed the medical device quality management system certification.